A New Discovery Service for Selective Separation Materials

Chromatography

A New Discovery Service for Selective Separation Materials

05 Apr, 2006

Published over 20 years ago. See the latest and most current information on Chromatography.

MIP Technologies AB is announcing ExploraSep?, a new screening concept for
selective separation. A continuously evolving library of molecularly imprinted
polymer (MIP) sorbents with a developing range of functional characteristics will be
used to discover ?hits' for customers who have demands in selective separation or
extraction. A key advantage of MIP materials is that they target specific molecules
or molecular classes leading to higher sensitivity, better efficiency and improved
productivity in the separation or extraction of chemical compounds from complex
mixtures.

"Screening libraries for drug hits in the Pharma industry is a normal everyday activity
but screening libraries to find separation materials is quite novel," said Dr Anthony
Rees, CEO of MIP Technologies. "Our approach will exploit the well known phenomenon
of ?cross-reactivity'. While a particular MIP may have been created with a particular
molecule or group of similar molecules in mind, the fact is there is no such thing as
absolute specificity so that other molecules will certainly be found to bind to the same
sites. We already have convincing demonstrations of the concept which we think will lift
separation technology to a new dimension."

Latest News

ILM 51.5 July 2026

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Envirotech Online
Throwable sensor offers rapid remote detection of chemical threats
Explore more Arrow
Pollution Solutions Online
Energy efficiency first: Why shipping must act now while low-GHG fuels scale
Explore more Arrow
Petro Online
Tunable infrared chip could sharpen gas leak and pollution detection
Explore more Arrow
Chromatography Today
SLAS Technology Volume 38 highlights AI-driven laboratory automation, transcriptomics and gene therapy
Explore more Arrow